Amphastar Pharmaceuticals, Inc.
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.19 | 0.45 | 1.04 | 1.33 | 1.16 | 0.56 | 0.70 | 0.74 | 1.10 | 0.70 | 1.03 | 1.16 | 4.17 | |
| 0.25 | 0.26 | 0.26 | 0.27 | -0.08 | 0.28 | 0.30 | 0.27 | 0.30 | 0.34 | 0.31 | 0.42 | 1.43 | |
| 0.09 | 0.09 | 0.14 | 0.11 | 0.11 | 0.11 | 0.17 | 0.13 | 0.13 | 0.13 | 0.20 | 0.16 | 0.65 | |
| -0.11 | -0.50 | -0.14 | 0.17 | -0.14 | -0.17 | -0.34 | -0.38 | 0.25 | -0.91 | 0.33 | -0.06 | -0.41 | |
| 0.19 | 0.18 | 0.17 | 0.12 | 0.27 | 0.24 | 0.21 | 0.22 | 0.11 | 0.18 | 0.20 | 0.19 | 0.72 | |
| -0.58 | -1.94 | 0.29 | -1.34 | -0.67 | -0.69 | 0.21 | -0.01 | -0.41 | -1.28 | -0.36 | 1.01 | -1.18 | |
| 0.04 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -0.93 | 1.10 | -0.33 | -0.16 | -0.67 | -0.81 | -0.22 | -0.81 | 1.05 | -0.43 | -0.63 | -1.02 | -1.02 | |
| – | – | – | – | 0.18 | 0.09 | 0.03 | 0.09 | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 | |
| 1.61 | -0.89 | -0.26 | -0.21 | -0.44 | -0.65 | -0.29 | -0.63 | -0.09 | -0.39 | -0.65 | -0.98 | -2.18 | |
| 2.22 | -2.39 | 1.07 | -0.22 | 0.05 | -0.78 | 0.62 | 0.10 | 0.60 | -0.98 | 0.02 | 1.19 | 0.81 | |
| 1.00 | 0.27 | 0.88 | 1.21 | 0.89 | 0.32 | 0.49 | 0.52 | 0.99 | 0.52 | 0.83 | 0.97 | 3.46 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.